Krebs Biochem

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
54.72
9.12 (20.0%)
BSENSE

Apr 06

BSE+NSE Vol: 33.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024

Compare Profit and Loss Results of Krebs Biochem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
43.00
302.00
-259.00
-85.76%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
43.00
302.00
-259.00
-85.76%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-7.00
10.00
142.86%
Raw Materials Consumed
2.00
164.00
-162.00
-98.78%
Power & Fuel Cost
18.00
8.00
10.00
125.00%
Employee Cost
16.00
61.00
-45.00
-73.77%
Operating Expenses
12.00
10.00
2.00
20.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
12.00
-12.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
58.00
272.00
-214.00
-78.68%
Operating Profit (PBDIT) excl Other Income
-15.00
30.00
-45.00
-150.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
-14.00
32.00
-46.00
-143.75%
Interest
5.00
17.00
-12.00
-70.59%
Profit before Depriciation and Tax
-20.00
15.00
-35.00
-233.33%
Depreciation
6.00
9.00
-3.00
-33.33%
Profit Before Taxation & Exceptional Items
-26.00
5.00
-31.00
-620.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-26.00
5.00
-31.00
-620.00%
Provision for Tax
0.00
-2.00
2.00
100.00%
Profit After Tax
-26.00
7.00
-33.00
-471.43%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-270.00
42.00
-312.00
-742.86%
Profit Available for appropriations
-297.00
50.00
-347.00
-694.00%
Appropriations
-297.00
50.00
-347.00
-694.00%
Equity Dividend (%)
0%
12%
-12.00
Earnings Per Share
-12.49
4.89
-17.38
-355.42%
Profit And Loss - Net Sales
Net Sales 43.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -15.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

Profit And Loss - Interest
Interest 5.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -26.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024